1. An overview of the Indian pharmaceutical industry -- 2. Patterns of trade in the Indian pharmaceutical industry -- 3. Pharmaceutical R&D in India -- 4. Intellectual property rights and access to medicines -- 5. The drug price control system in India and access to medicines.

"At present India is a leading producer, distributor, and consumer of generic medicines globally. Disparate Remedies traces the genealogy of this development and examines the public cultures of medicine in the country between 1870 and 1960. The book begins by discussing the expansion of medical...

The outbreak of COVID-19 in Wuhan, China and the lockdown that followed had disrupted the supply of APIs and their intermediates and starting materials to India, leading to a temporary restriction on export of certain medicines from India. The PLI scheme that was announced subsequently aimed at...

The TRIPS agreement has been one of the most contentious agreements of WTO. The pharmaceutical industry has been central to this debate, especially the case of India, which did not recognize product patents in pharmaceuticals before TRIPS and evolved as a major pharmaceuticals manufacturer and...

This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs. The results of a survey of three states...

India has one of the most advanced pharmaceutical industries among developing countires. Yet India is critically dependent on China for supplies of build drugs and drug intermediates with China accounting for about two-thirds of the total imports. In the early 1990s, China was relatively a minor...